Forward-Looking StatementsThis press release contains forward-looking statements on Anavex Life Sciences Corp., subject to certain risks subject to certain risks and uncertainties. Actual events or results may differ materially from get information . In such statements due to various factors Among others, there is no guarantee that any of the Company’s development efforts relating to its product candidate, ANAVEX 1-41, will be successful, or such product candidates will be successfully commercialized or that ANAVEX 1-41 will have the potential to his the treatment of Alzheimer ‘s disease or other types of neurodegenerative diseases or that ANAVEX 1-41 is clinically relevant advantages over other competitive compounds in development. Affect other risks that forward-looking information contained in this news release, the high risks with with drug development, details the results of further research and development, the effects of competition and technological progress and other ANAVEX ANAVEX the SEC. Other than required by U.S. Federal securities laws, we undertake no obligation to publicly update or revise the forward-looking statements, whether as a result of changed circumstances, new information, future events or otherwise, after the date of this press release.
This press release contains forward-looking statements, management expectations management expectations differ these statements. Asked materially from actual future events or results due to certain risks and uncertainties, including, without limitation, risks associated with the drug development and manufacturing risks in the extensive approval process by the United States Food and Drug Administration and the Australian Therapeutic Goods Administration, delays obtaining the necessary approvals for clinical testing, patient recruitment, delays in the implementation of clinical trials, market acceptance of PI-88, PI-166 and other drugs, future capitals needs, general economic conditions and other risks and uncertainties, the detailed time to time in the company’s filings with the Australian Stock Exchange and the United States Securities and Exchange Commission. Moreover, there is no guarantee that others do not like to be independently develop products or processes or design around patents owned or licensed by the Company, or that patents owned or licensed by the Company will be meaningful protection or competitive advantages.
However, a new report was of the Independent Police Complaints Commission, that most of the people who are noted in unfit custody – made rather than to dedicated estimate institutions for mental health unit.
Police departments may its daunting places, especially when people feeling fragile and despair, and service users, the police can be picked cells feel both unsafe and criminalized. A barren, people spend around 9 hours in police custody before being sanity mental health physician – although some cases some cases may discharge without ever having a mental health laborers. – A service users which wrote report 24 hours that he spent in a police cell,:.